The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population

被引:30
|
作者
Hu, Haofei [1 ,2 ,5 ]
Han, Yong [3 ,4 ,5 ]
Cao, Changchun [6 ]
He, Yongcheng [7 ]
机构
[1] Shenzhen Univ, Affiliated Hosp 1, Dept Nephrol, Shenzhen 518000, Guangdong, Peoples R China
[2] Shenzhen Second Peoples Hosp, Dept Nephrol, Shenzhen 518000, Guangdong, Peoples R China
[3] Shenzhen Second Peoples Hosp, Dept Emergency, Shenzhen 518000, Guangdong, Peoples R China
[4] Shenzhen Univ, Affiliated Hosp 1, Dept Emergency, Shenzhen 518000, Guangdong, Peoples R China
[5] Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518071, Guangdong, Peoples R China
[6] Shenzhen Dapeng New Dist Nanao Peoples Hosp, Dept Rehabil, 6,Renmin Rd, Shenzhen 518000, Guangdong, Peoples R China
[7] Shenzhen Hengsheng Hosp, Dept Nephrol, 20 Yintian Rd, Shenzhen 518000, Guangdong, Peoples R China
关键词
Non-alcoholic fatty liver disease; Triglyceride glucose-body mass index; Negative predictive value; Receiver operating characteristic; Positive predictive value; ULTRASOUND HEPATIC/RENAL RATIO; AMERICAN ASSOCIATION; INSULIN-RESISTANCE; METABOLIC SYNDROME; ATTENUATION RATE; DIAGNOSIS; STEATOSIS; LIPOTOXICITY; ELASTOGRAPHY; VALIDATION;
D O I
10.1186/s12967-022-03611-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background By identifying individuals at high risk for non-alcoholic fatty liver disease (NAFLD), interventional programs could be targeted more effectively. Some studies have demonstrated that triglyceride glucose-body mass index (TyG-BMI) showed an independent positive association with NAFLD. However, research on its diagnostic value in patients with suspected NAFLD is limited. In this study, we aimed to evaluate whether TyG-BMI was accurate in detecting NAFLD in the general Japanese population. Methods A cross-sectional study of 14,280 individuals who underwent a comprehensive health examination was conducted. Standard protocols were followed to collect anthropometric measurements, lab data, and ultrasonography features. All participants were randomly stratified into the development group (n = 7118) and validation group (n = 7162). The TyG-BMI was calculated. Following this, the diagnostic value of the TyG-BMI was evaluated based on the area under the receiver-operating characteristic curve (AUROC). Two cutoff points were selected and used to rule out or rule in the NALFD, and the specificity, sensitivity, negative predictive value, and positive predictive value were explored, respectively. In order to verify the stability of the results, external verification was performed. Results There were 1272 and 1243 NAFLD participants in the development and validation groups, respectively. The area under the ROC curve (AUC) of TyG-BMI was 0.888 (95% CI 0.876-0.896) and 0.884 (95% CI 0.875-0.894) for the training and validation group, respectively. Using the low TyG-BMI (182.2) cutoff, NAFLD could be excluded with high accuracy (negative predictive value: 96.9% in estimation and 96.9% in validation). The presence of NAFLD could effectively be determined by applying the high cutoff of TyG-BMI (224.0), as the positive predictive value of the estimation and validation groups is 70.7% and 70.1%, respectively. As a result of applying this model, 9996 (70%) of the 14,280 participants would not have undergone ultrasonography, with an accurate prediction of 9308 (93.1%). AUC was 0.874 for external validation using 183,730 Chinese non-obese participants. TyG-BMI was demonstrated to be an excellent diagnostic tool by both internal and external validation. Conclusions In conclusion, the present study developed and validated a simple, non-invasive, and cost-effective tool to accurately separate participants with and without NAFLD in the Japanese population, rendering ultrasonography for identifying NAFLD unnecessary in a substantial proportion of people.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Non-invasive tests of non-alcoholic fatty liver disease
    Li Guanlin
    Zhang Xinrong
    Lin Huapeng
    Liang Lilian Yan
    Wong Grace Lai-Hung
    Wong Vincent Wai-Sun
    中华医学杂志英文版, 2022, 135 (05) : 532 - 546
  • [22] NON-INVASIVE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
    Gallego-Duran, R.
    Cerro-Salido, P.
    Pareja, M. J.
    Ranchal, I.
    Rico, M. C.
    Rojas, L.
    Aznar, R.
    Bugianesi, E.
    Crespo, J.
    Arias-Loste, M. T.
    Abad, J.
    Soto, S.
    Aparcero, R.
    Moreno, I.
    Calleja, J. L.
    Lo Iacono, O.
    Andrade, R.
    Gomez-Gonzalez, E.
    Romero-Gomez, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S349 - S350
  • [23] Non-invasive tests of non-alcoholic fatty liver disease
    Li, Guanlin
    Zhang, Xinrong
    Lin, Huapeng
    Liang, Lilian Yan
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    CHINESE MEDICAL JOURNAL, 2022, 135 (05) : 532 - 546
  • [24] Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects
    Zhang, Shujun
    Du, Tingting
    Li, Mengni
    Jia, Jing
    Lu, Huiming
    Lin, Xuan
    Yu, Xuefeng
    MEDICINE, 2017, 96 (22)
  • [25] Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index
    Petta, S.
    Di Marco, V.
    Camma, C.
    Butera, G.
    Cabibi, D.
    Craxi, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (12) : 1350 - 1360
  • [26] Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Tincopa, Monica A.
    Loomba, Rohit
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (07): : 660 - 670
  • [27] Association between the Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation
    Li, Xiaozhong
    Zhan, Fenfang
    Peng, Tian
    Xia, Zhen
    Li, Juxiang
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [28] Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease
    Liguori, Antonio
    Zoncape, Mirko
    Tsochatzis, Emmanuel A.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (04) : 191 - 194
  • [29] Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
    Basheer, Maamon
    Naffaa, Mohamed
    Assy, Nimer
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (02) : 398 - 400
  • [30] Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
    Stergios Kechagias
    Mattias Ekstedt
    Christian Simonsson
    Patrik Nasr
    Hormones, 2022, 21 : 349 - 368